We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

83 hedge funds and large institutions have $112M invested in BioDelivery Sciences International, Inc. in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,879% more call options, than puts

Call options by funds: $277K | Put options by funds: $14K

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

80% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 15

40% more capital invested

Capital invested by funds: $79.9M → $112M (+$31.6M)

22% more funds holding

Funds holding: 6883 (+15)

Holders
83
Holders Change
+15
Holders Change %
+22.06%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
22
Increased
27
Reduced
15
Closed
7
Calls
$277K
Puts
$14K
Net Calls
+$263K
Net Calls Change
+$95K
Name Holding Trade Value Shares
Change
Change in
Stake
ACA
1
Avoro Capital Advisors
New York
$15.2M
BC
2
Broadfin Capital
New York
$12.3M +$270K +96,247 +2%
SCM
3
Stonepine Capital Management
Oregon
$12.1M +$7.93M +2,825,101 +190%
AC
4
Armistice Capital
New York
$9.22M +$8.9M +3,171,111 +2,623%
Vanguard Group
5
Vanguard Group
Pennsylvania
$6.67M +$21.3K +7,600 +0.3%
CAM
6
Cortina Asset Management
Wisconsin
$5.51M +$164K +58,358 +3%
NCM
7
Nantahala Capital Management
Connecticut
$4.67M +$4.68M +1,666,667 New
GTC
8
Ghost Tree Capital
New York
$4.2M +$249K +88,753 +6%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$4.2M +$2.53M +900,000 +150%
AOWM
10
Alpha Omega Wealth Management
Virginia
$3.67M +$427K +152,062 New
JFA
11
JNBA Financial Advisors
Minnesota
$3.67M +$427K +152,062 New
BlackRock
12
BlackRock
New York
$3.36M +$23.9K +8,503 +0.7%
Ameriprise
13
Ameriprise
Minnesota
$3.18M +$62.9K +22,400 +2%
FCMI
14
Foresite Capital Management II
California
$2.66M +$2.58M +918,733 +3,012%
William Blair & Company
15
William Blair & Company
Illinois
$2.21M +$227K +80,975 +11%
FCMI
16
Foresite Capital Management III
California
$1.76M +$1.71M +610,156 +3,129%
FI
17
Fosun International
China
$1.46M +$1.55M +551,538 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$1.43M +$32.7K +11,651 +2%
RA
19
Royce & Associates
New York
$1.35M -$4.82M -1,717,200 -78%
EIM
20
Essex Investment Management
Massachusetts
$1.06M +$1.06M +377,438 New
DMK
21
David M. Knott
$1.05M +$466K +166,000 +80%
1CM
22
1492 Capital Management
Wisconsin
$897K +$900K +320,523 New
JP Morgan Chase
23
JP Morgan Chase
New York
$750K +$198K +70,633 +36%
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$726K
FM
25
Fondren Management
Texas
$560K -$84.7K -30,180 -13%

BDSI Hedge Fund Activity: Q3 2018 in Review

83 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2018, worth a combined $112M — up 40% from $79.9M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new BDSI positions and 7 closed out — a net gain of 15 holders — while 27 added to existing stakes and 15 trimmed.

The largest buyer was Armistice Capital, adding an estimated $8.9M. The largest seller was Royce & Associates, cutting an estimated $4.82M.

  • 83 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2018, up from 68 in Q2 2018.
  • Funds reported $112M of BioDelivery Sciences International, Inc. stock for Q3 2018, up 40% quarter-over-quarter.
  • 22 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2018 and 7 closed out, a net change of +15 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q3 2018 was Armistice Capital, an estimated $8.9M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q3 2018 was Royce & Associates, an estimated $4.82M sold.

Based on aggregated 13F filings for Q3 2018.